ADDvise Group issues a senior secured bond loan of 250 MSEK

12-05-2021   Regulatory press release

ADDvise Group AB (publ) ("ADDvise" or the "Company") announces today that the Company has successfully placed a senior secured bond loan with an initial volume of 250 MSEK within a framework of 500 MSEK. The bond has a tenor of three years and carries interest at an annual rate of 3 months STIBOR plus 725 basis points. ADDvise intends to apply for listing of the bond on the Corporate Bond List of Nasdaq Stockholm. The bond issue saw strong demand from both Nordic and international primarily institutional investors and was significantly oversubscribed.

As previously communicated to the market via a press release on May 12, the net proceeds from the bond loan will be used to repay the Company's outstanding bonds and other credit facilities and to finance general corporate purposes including future acquisitions.

- I am pleased with the positive responses we received from investors. We are now refinancing our retail bond with an institutional bond. A frame of 500 MSEK gives us the possibility to accelerate our acquisition strategy, says Rikard Akhtarzand, CEO.

Pareto Securities AB acted as financial advisor and Roschier Advokatbyrå as legal advisor in connection with the bond issue.

For additional information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 12 May 2021 at 17:45 CEST.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy, which aims to increase shareholder value through expanding the business from a geographical and product standpoint. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise completes the acquisition of MRC Systems FZE

Regulatory

ADDvise Group AB (publ) (”ADDvise”) has today completed the acquisition of all shares in MRC Systems FZE (”MRC”). The signing of the share purchase agreement has been communicated to the market via a press release on 16 February 2021. The total purchase price amounts to USD 8.00 million, of which USD 4.50 million has been…

ADDvise signs Letter of Intent to acquire Medisuite, LLC

Regulatory

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Medisuite, LLC (”Medisuite”) regarding an acquisition of 100 percent of the shares in Medisuite. Medisuite is an American online pharmacy that specializes in medication for men’s health. The prescription medication that is marketed by Medisuite is mainly used for treatment of…

ADDvise Group to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds

Regulatory

ADDvise Group AB (publ) (“ADDvise") hereby announces that ADDvise’s up to SEK 240,000,000 senior unsecured callable floating rate bonds with ISIN SE0010298166 (the "Bonds"), will be redeemed in advance in accordance with Clause 8.3 (Voluntary total redemption (call option)) of the terms and conditions of the Bonds. The redemption date will be 18 June 2021.…